Samten Ongmu Bhutia
About Samten Ongmu Bhutia
Data last updated:
Samten Ongmu Bhutia is a Director at Neohealth Pathology Labs Private Limited (since 2020). The company operates in Healthcare. Neohealth Pathology Labs Private Limited reported revenue of ₹10 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neohealth Pathology Labs Private Limited U85320UP2020PTC126959 | Director | 12 Feb 2020 | 2020 | ₹10 Lakh (FY 2025) | Active |
Board colleagues of Samten Ongmu Bhutia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Kumar Dubey | 08697536 | Neohealth Pathology Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samten Ongmu Bhutia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samten Ongmu Bhutia
Samten Ongmu Bhutia currently holds 1 directorship: Neohealth Pathology Labs Private Limited (Director, since 12 Feb 2020, revenue ₹10 Lakh (FY 2025)).
Samten Ongmu Bhutia was first appointed on 12 Feb 2020 as Director at Neohealth Pathology Labs Private Limited.
The current boards of Samten Ongmu Bhutia's companies include Arun Kumar Dubey (Neohealth Pathology Labs Private Limited).